Skip to main content
Cureus logoLink to Cureus
. 2024 Mar 20;16(3):c166. doi: 10.7759/cureus.c166

Correction: Exploring a New Entity of Single-Agent Pembrolizumab-Associated Hypophysitis

Eric Balti 1,, Sarah Verhaeghe 1, Vibeke Kruse 2,3,4, Stijn Roels 5, Peter Coremans 1
Editors: Alexander Muacevic, John R Adler
PMCID: PMC10955672  PMID: 38516288

This article has been corrected to accurately reflect author Vibeke Kruse’s affiliations. The following affiliations have been added:

Department of Molecular Imaging, Pathology, Radiotherapy and Oncology (MIPRO), University of Antwerp, Wilrijk, Belgium Department of Oncology, Antwerp University Hospital, Edegem, Belgium

The authors deeply regret that this was not noticed prior to publication.

 

No competing interests declared.


Articles from Cureus are provided here courtesy of Cureus Inc.

RESOURCES